Early Career Investigators: Participate in a hands-on mentoring workshop to increase your productivity in women’s health research
Application Deadline: December 22nd, 2023
The National Heart, Lung, and Blood Institute (NHLBI) and the Office of Research on Women’s Health (ORWH) invite early career investigators (postdoctoral and early stage investigators ESIs) in biomedical research to apply to attend the Women’s Health across the Lifespan Cohort Workshop from March 6th– 8th, 2024 in Bethesda, MD. This is an exciting opportunity to gain hands-on mentoring directly with senior investigators of the Women’s Health Initiative (WHI) and nuMoM2b Heart Health (nuMoM2b HHS) studies and enhance your publication record in women’s health across the lifespan.
Eligibility: Junior faculty, early stage investigators (ESIs) and postdoctoral fellows with a Ph.D., M.D. or equivalent are eligible to apply. Applicants from resource-limited institutions (RLIs)*, those who identify as a underrepresented research minority (URM) and those without prior K awards or other funding are strongly encouraged to apply.
What to expect: Due to the hands-on mentoring nature of this workshop, interested participants must submit an application to be considered for attendance. Applicants should consider a novel question that could be answered, using one or both of the datasets and complete the manuscript proposal. During the workshop, scholars will work closely with their assigned mentors to develop and refine the proposed manuscript for publication. Travel, hotel and meals is at the expense of the participants.
About the Cohort Studies
WHI: The Women’s Health Initiative Study is one of NHLBI’s landmark studies in women’s health. Starting in 1993, this study enrolled a diverse group (Black, Hispanic/Latino, White, Asian, Native Hawaiian or Pacific Islander, and American Indian or Alaskan Native) of over 161,000 postmenopausal women. Of these, 27,347 participated in the Hormone Therapy (HT) Trial whose findings led to a change in recommendations related to hormone therapy in postmenopausal women. WHI also includes 36,282 women who participated in a calcium and vitamin D trial, and 48,835 women who participated in the dietary modification trial which investigated the effects of a low fat diet on health outcomes. WHI continues to follow all 52,000 living participants. More information can be found here.
nuMoM2b HHS: The nuMoM2b Heart Health Study follows about 7,000 women who were enrolled in the original nuMoM2b study (of 10,000 women) that ascertained adverse pregnancy outcomes during a carefully phenotyped first pregnancy. nuMoM2b HHS continues to explore the relationship between pregnancy outcomes and future heart, vascular, sleep and brain health in this richly diverse population. More information can be found here.
To apply to the workshop, please use this link.
More information will be available online soon, but if you have any questions about the workshop or the application, feel free to contact us: nhlbicohortstudies@nhlbi.nih.gov.